Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000939767-21-000112
Filing Date
2021-12-17
Accepted
2021-12-17 20:29:32
Documents
4
Period of Report
2021-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_163979095685871.html 3  
1 FORM 3 wf-form3_163979095685871.xml 3 1698
2 POWER OF ATTORNEY, EXHIBIT 24 JACQUELINE WRIGHT powerofattorney-jackywri.htm EX-24 991
3 POWER OF ATTORNEY JPEG powerofattorney-jackywri001.jpg GRAPHIC 265618
4 POWER OF ATTORNEY JPEG2 powerofattorney-jackywri002.jpg GRAPHIC 141035
  Complete submission text file 0000939767-21-000112.txt   564585
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Issuer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1665 UTICA AVENUE SUITE 700 ST. LOUIS PARK MN 55416
Business Address
Wright Jacqueline (Reporting) CIK: 0001806405 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30235 | Film No.: 211503384